Skip to content

Enovis ENOV Share Repurchase Authorization Limit

Share Repurchase Authorization Limit at other companies

ESAB logo
ESABESAB
0
Hinge Health, Inc. logo
Hinge Health, Inc.HNGE
$80M
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$250M
Baxter International logo
Baxter InternationalBAX
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept srt:StockRepurchaseProgramAuthorizedAmount1.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's share repurchase authorization limit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's share repurchase authorization limit?
Enovis (ENOV) reported share repurchase authorization limit of $100M in Q1 2026.
How has Enovis's share repurchase authorization limit changed year-over-year?
Enovis's share repurchase authorization limit decreased by 0.0% year-over-year, from $100M to $100M.
What does share repurchase authorization limit mean?
This represents the total dollar value or share count that the board of directors has authorized the company to spend on repurchasing its own common stock from the open market. It serves as a signal of management's confidence in the company's valuation and its commitment to returning capital to shareholders. This limit is an authorization, not an obligation to spend.